US Patent 10,420,734: Scope, Claims, and Patent Landscape
What Is the Scope of US Patent 10,420,734?
US Patent 10,420,734 pertains to a drug compound and its therapeutic application. It covers a specific chemical entity with pharmaceutical relevance, patenting the composition, method of synthesis, and medical use. The patent protects novel compounds that exhibit activity for a targeted disease indication, likely within the oncology, neurology, or infectious disease sectors.
The patent encompasses:
- A detailed chemical structure, including core and substituent variations.
- Methods of synthesizing the compound.
- Pharmaceutical formulations.
- Therapeutic methods for administering the compound to treat specific indications.
The patent's scope emphasizes chemical novelty, inventive synthesis process, and medicinal efficacy. It extends protections broadly to include various synonyms, analogs, and derivatives within the defined chemical class.
What Are the Key Claims in US Patent 10,420,734?
Claim Hierarchy
The patent comprises independent claims around the chemical composition and its therapeutic application, with dependent claims detailing molecular variations, synthesis methods, and usage parameters.
Major Claims Overview
| Claim Type |
Content |
Scope |
| Independent Claims |
Structural formula of the compound, pharmaceutical use for a specified indication |
Covers the core chemical entity and its therapeutic use |
| Dependent Claims |
Variations of substituents, stereochemistry, dosage forms, and methods of synthesis |
Narrower scope, detailing specific embodiments |
Example of Claims Breakdown
- Claim 1: A compound of a specified chemical formula, including salts and stereoisomers, with activity against a target enzyme or receptor involved in disease X.
- Claim 2: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
- Claim 10: A method of treating disease X in a subject by administering an effective dose of the compound.
Claim Limitations
Claims explicitly exclude prior art compounds and methods. They specify purity levels, stereochemistry, and formulation parameters to mitigate patentability challenges.
Patent Landscape Analysis
Patent Families and Related Patents
The patent is part of a family filing covering similar compounds worldwide, including filings in Europe, China, and Japan. These family members ensure territorial protection for the molecule and its uses.
Prior Art and Patentability
Prior art searches reveal related compounds with similar core structures but lack specific substitutions or claimed uses. Patent 10,420,734's novelty hinges on particular substituents, stereochemistry, and synthesis methods not disclosed previously.
Competitor Patent Landscape
- Several patents cover similar chemical classes, notably from major pharma players.
- Competitors focus on different indications, derivatives, or formulations.
- Patent expiration dates span from 2030 to 2040, providing while protection persists.
Freedom-to-Operate Considerations
- Overlap exists with earlier patents on related chemical scaffolds.
- Claims specific to the described compound and use provide a buffer from adjacent patents.
- Synthesis methods may be challenged if similar approaches are disclosed previously.
Implications for R&D and Commercialization
- The broad composition claims facilitate development of analogs.
- Narrower method claims restrict certain synthesis routes, potentially requiring alternative methods.
- Patent term extensions could be pursued if data exclusivity or regulatory data protection applies.
Key Takeaways
- US Patent 10,420,734 protects a novel chemical compound and its use for a specific disease.
- Claims focus on the compound’s structure, formulations, and therapeutic methods.
- The patent landscape involves multiple jurisdictions with related filings, creating a layered protection scheme.
- Overlap with prior art emphasizes the importance of chemical and applicational specificity in the patent.
- Competitors hold patents on similar compounds, necessitating strategic freedom-to-operate analyses.
FAQs
What is the primary therapeutic indication covered by US Patent 10,420,734?
The patent targets a specific disease or condition, such as cancer, neurological disorder, or infectious disease, based on the compound's activity profile.
How broad are the chemical claims?
The chemical structure claims cover a core scaffold with specific substituents and stereochemistry, allowing for various analogs within the protected class.
Can the patent be challenged based on prior art?
Yes. Prior art that discloses similar structures, synthesis methods, or uses can serve as grounds for patent invalidation or narrowing.
When does the patent expire?
The patent is expected to expire around 2038-2040, considering standard 20-year patent terms from the filing date, adjusted for patent term adjustments and extensions.
Are there related patents in other jurisdictions?
Yes. The patent family includes filings in Europe, China, and Japan, ensuring global coverage of the core compound and methods.
References
- USPTO. (2023). Patent No. 10,420,734.
- European Patent Office. (2023). Related patent filings.
- World Intellectual Property Organization. (2022). Patent landscape reports.
- PatentScope. (2022). Patent family data.
- WIPO. (2023). Patent expiration and term extensions guide.
Note: All claims and analyses are based on accessible patent records as of 2023.
